Abbott Laboratories (XSGO:ABT) EV-to-Revenue : 4.82 (As of Apr. 30, 2024)

View and export this data going back to 2013. Start your Free Trial

What is Abbott Laboratories EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Abbott Laboratories's enterprise value is $194,482 Mil. Abbott Laboratories's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $40,326 Mil. Therefore, Abbott Laboratories's EV-to-Revenue for today is 4.82.

The historical rank and industry rank for Abbott Laboratories's EV-to-Revenue or its related term are showing as below:

XSGO:ABT' s EV-to-Revenue Range Over the Past 10 Years
Min: 2.64 Med: 4.45 Max: 7
Current: 4.82

During the past 13 years, the highest EV-to-Revenue of Abbott Laboratories was 7.00. The lowest was 2.64. And the median was 4.45.

XSGO:ABT's EV-to-Revenue is ranked worse than
65.49% of 823 companies
in the Medical Devices & Instruments industry
Industry Median: 3.16 vs XSGO:ABT: 4.82

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-30), Abbott Laboratories's stock price is $112.41. Abbott Laboratories's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $23.06. Therefore, Abbott Laboratories's PS Ratio for today is 4.87.

Abbott Laboratories EV-to-Revenue Historical Data

The historical data trend for Abbott Laboratories's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott Laboratories EV-to-Revenue Chart

Abbott Laboratories Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

5.27

5.97

4.55

4.97

Abbott Laboratories Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial															4.43	4.92	4.43	4.97	-

Competitive Comparison of Abbott Laboratories's EV-to-Revenue

For the Medical Devices subindustry, Abbott Laboratories's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Abbott Laboratories's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Abbott Laboratories's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Abbott Laboratories's EV-to-Revenue falls into.

Abbott Laboratories EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Abbott Laboratories's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	194482.219	/	40326
	=	4.82

Abbott Laboratories's current Enterprise Value is $194,482 Mil.
Abbott Laboratories's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $40,326 Mil.

Abbott Laboratories (XSGO:ABT) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Abbott Laboratories's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	112.41	/	23.063
	=	4.87

Abbott Laboratories's share price for today is $112.41.
Abbott Laboratories's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $23.06.

Abbott Laboratories EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Abbott Laboratories's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Abbott Laboratories (XSGO:ABT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Abbott Laboratories (XSGO:ABT) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

ABT:USA ABT:Mexico 0Q15:UK ABL:Germany ABT:Switzerland ABTT34:Brazil ABT:Austria ABT:Argentina

Address

100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400

Website

https://www.abbottinvestor.com

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.